These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12915156)

  • 1. Quantitative measures for assessing rheumatoid arthritis in clinical trials and clinical care.
    Pincus T; Sokka T
    Best Pract Res Clin Rheumatol; 2003 Oct; 17(5):753-81. PubMed ID: 12915156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The American College of Rheumatology (ACR) Core Data Set and derivative "patient only" indices to assess rheumatoid arthritis.
    Pincus T
    Clin Exp Rheumatol; 2005; 23(5 Suppl 39):S109-13. PubMed ID: 16273794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.
    Felson DT; Anderson JJ; Boers M; Bombardier C; Chernoff M; Fried B; Furst D; Goldsmith C; Kieszak S; Lightfoot R
    Arthritis Rheum; 1993 Jun; 36(6):729-40. PubMed ID: 8507213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.
    Pincus T; Richardson B; Strand V; Bergman MJ
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-47-54. PubMed ID: 25365089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis.
    Pincus T
    Bull NYU Hosp Jt Dis; 2008; 66(3):216-23. PubMed ID: 18937635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures of activity and damage in rheumatoid arthritis: depiction of changes and prediction of mortality over five years.
    Callahan LF; Pincus T; Huston JW; Brooks RH; Nance EP; Kaye JJ
    Arthritis Care Res; 1997 Dec; 10(6):381-94. PubMed ID: 9481230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative documentation of benefit/risk of new therapies for rheumatoid arthritis: patient questionnaires as an optimal measure in standard care.
    Pincus T; Sokka T; Kavanaugh A
    Clin Exp Rheumatol; 2004; 22(5 Suppl 35):S26-33. PubMed ID: 15552511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical measures in rheumatoid arthritis: which are most useful in assessing patients?
    Ward MM
    J Rheumatol; 1994 Jan; 21(1):17-27. PubMed ID: 7864914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
    Castrejón I; Dougados M; Combe B; Guillemin F; Fautrel B; Pincus T
    J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials.
    Pincus T; Amara I; Segurado OG; Bergman M; Koch GG
    J Rheumatol; 2008 Feb; 35(2):201-5. PubMed ID: 18050378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations.
    Sokka T; Pincus T
    Rheum Dis Clin North Am; 2009 Nov; 35(4):713-22, v-vi. PubMed ID: 19962615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial control of Core Data Set measures and Disease Activity Score (DAS) measures of inflammation does not prevent long-term joint damage: evidence from longitudinal observations over 5-20 years.
    Pincus T; Sokka T
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S42-7. PubMed ID: 14989429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposed continuous quality improvement approach to assessment and management of patients with rheumatoid arthritis without formal joint counts, based on quantitative routine assessment of patient index data (RAPID) scores on a multidimensional health assessment questionnaire (MDHAQ).
    Pincus T; Yazici Y; Bergman M; Maclean R; Harrington T
    Best Pract Res Clin Rheumatol; 2007 Aug; 21(4):789-804. PubMed ID: 17678835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.
    Felson DT; Smolen JS; Wells G; Zhang B; van Tuyl LH; Funovits J; Aletaha D; Allaart CF; Bathon J; Bombardieri S; Brooks P; Brown A; Matucci-Cerinic M; Choi H; Combe B; de Wit M; Dougados M; Emery P; Furst D; Gomez-Reino J; Hawker G; Keystone E; Khanna D; Kirwan J; Kvien TK; Landewé R; Listing J; Michaud K; Martin-Mola E; Montie P; Pincus T; Richards P; Siegel JN; Simon LS; Sokka T; Strand V; Tugwell P; Tyndall A; van der Heijde D; Verstappen S; White B; Wolfe F; Zink A; Boers M
    Ann Rheum Dis; 2011 Mar; 70(3):404-13. PubMed ID: 21292833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
    Pincus T; Yazici Y; Bergman MJ
    Rheum Dis Clin North Am; 2009 Nov; 35(4):773-8, viii. PubMed ID: 19962621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures.
    Pincus T; Callahan LF; Brooks RH; Fuchs HA; Olsen NJ; Kaye JJ
    Ann Intern Med; 1989 Feb; 110(4):259-66. PubMed ID: 2913913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.
    Pincus T; Bergman MJ; Yazici Y; Hines P; Raghupathi K; Maclean R
    Rheumatology (Oxford); 2008 Mar; 47(3):345-9. PubMed ID: 18238788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
    Yazici Y; Bergman M; Pincus T
    J Rheumatol; 2008 Apr; 35(4):603-9. PubMed ID: 18322993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assessment of disease activity by patients with rheumatoid arthritis.
    Hanly JG; Mosher D; Sutton E; Weerasinghe S; Theriault D
    J Rheumatol; 1996 Sep; 23(9):1531-8. PubMed ID: 8877920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.